- Home
- ROIV vs INGR Comparison
ROIV vs INGR Comparison
Compare ROIV & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- INGR
- Stock Information
- Founded
- ROIV 2014
- INGR 1906
- Country
- ROIV United Kingdom
- INGR United States
- Employees
- ROIV N/A
- INGR N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- INGR Packaged Foods
- Sector
- ROIV Health Care
- INGR Consumer Staples
- Exchange
- ROIV Nasdaq
- INGR Nasdaq
- Market Cap
- ROIV 8.6B
- INGR 8.6B
- IPO Year
- ROIV N/A
- INGR 1997
- Fundamental
- Price
- ROIV $15.28
- INGR $123.77
- Analyst Decision
- ROIV Strong Buy
- INGR Hold
- Analyst Count
- ROIV 4
- INGR 5
- Target Price
- ROIV $15.50
- INGR $151.40
- AVG Volume (30 Days)
- ROIV 7.8M
- INGR 445.1K
- Earning Date
- ROIV 11-11-2025
- INGR 11-04-2025
- Dividend Yield
- ROIV N/A
- INGR 2.58%
- EPS Growth
- ROIV N/A
- INGR 4.50
- EPS
- ROIV N/A
- INGR 10.23
- Revenue
- ROIV $23,233,000.00
- INGR $7,316,000,000.00
- Revenue This Year
- ROIV N/A
- INGR $2.02
- Revenue Next Year
- ROIV $281.14
- INGR $2.45
- P/E Ratio
- ROIV N/A
- INGR $12.14
- Revenue Growth
- ROIV N/A
- INGR N/A
- 52 Week Low
- ROIV $8.73
- INGR $120.51
- 52 Week High
- ROIV $16.05
- INGR $155.44
- Technical
- Relative Strength Index (RSI)
- ROIV 82.00
- INGR 36.63
- Support Level
- ROIV $13.81
- INGR $123.36
- Resistance Level
- ROIV $14.48
- INGR $127.19
- Average True Range (ATR)
- ROIV 0.47
- INGR 1.95
- MACD
- ROIV 0.22
- INGR -0.26
- Stochastic Oscillator
- ROIV 81.67
- INGR 5.76
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About INGR Ingredion Incorporated
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.